Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-025827

Chief Executive Officer sold 335,019 shares at an average $26.26 ($8,798,952)

  • Chief Executive Officer gave up 451,189 shares (to pay taxes)
  • Chief Executive Officer acquired 800,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2022-07-06 Option exercise +800,000 $2.08 $1,664,000 800,000 D
BELANOFF JOSEPH K Chief Executive Officer 2022-07-06 Shares withheld for taxes −451,189 $26.21 $11,825,664 348,811 D
BELANOFF JOSEPH K Chief Executive Officer 2022-07-06 Sale −279,908 $26.27 $7,352,008 2,538,218 I
BELANOFF JOSEPH K Chief Executive Officer 2022-07-07 Sale −55,111 $26.26 $1,446,945 2,483,107 I
Derivatives
BELANOFF JOSEPH K Chief Executive Officer 2022-07-06 Option exercise · Stock option (right to buy) +800,000 0 D
Open-market sales · 335,019 sh · avg $26.26 · $8,798,952
Loading xslF345X03/doc4.xml…